Partner with us to bring your studies to our clinical research unit and achieve your drug development goals.
At Worldwide, we’re equipped to handle your early phase clinical trials with precision and efficiency. We offer a full suite of services, including medical and scientific consultation, protocol design, and clinical and medical monitoring, all under one set of SOPs. Our 200-bed Phase I facility in San Antonio, TX, is designed to meet the complex needs of early phase research, with a one-hour travel time to a GLP bioanalytical lab for rapid sample analysis. Our on-site cGMP pharmacy supports dose compounding and secure storage, and our CLIA safety lab ensures quick turnaround of test results. In addition, we have a proven track record of rapid response to FDA mandates and a strong commitment to data integrity and subject safety.
We can conduct special procedures within our clinic, such as a comprehensive suite of cognitive assessments, electroencephalograms (EEG), CSF collections, 24-hour telemetry, AME studies, and more.
We have the experience and expertise to take on all of your clinical pharmacology studies. From First-in-Human (FIH) to hepatic impairment, we’re here to support your trial so that you can move on to your next critical milestone.
We’ve expanded our on-site pharmacy, allowing us to manufacture in real-time for Phase I studies per FDA guidance. Additionally, we offer an on-site CLIA-certified safety laboratory fully dedicated to research studies.
Highly flexible, fit-for-purpose facility in San Antonio, TX
Current On-Time YTD Dosing
Year track record across a wide range of ClinPharm studies, from design to report
Chief Scientific Officer, Early Phase Development
Executive Vice President and General Manager, Early Phase
Senior Vice President, Clinical Operations Early Phase
Over 80% of respondents agreed that midsize CROs, such as Worldwide, provide a strong cultural fit while being able to pivot quickly based on changing customer needs.